MoonLake Immunotherapeutics (MLTX)
↓ Download CSVKey ratios (FY2025)
-74.7%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Operating Income | -$244.83M | -$143.09M | -$54.12M | -$65.06M | -$4.57M | — |
| Net Income | -$227.32M | -$118.94M | -$36.01M | -$49.97M | -$4.54M | — |
| EPS (Diluted) | $-3.53 | $-1.89 | $-0.73 | $-1.70 | — | — |
| Total Assets | $424.43M | $477.93M | $526.54M | $76.84M | $9.68M | $116.63M |
| Total Liabilities | $119.95M | $24.54M | $13.05M | $8.08M | $21.33M | $4.15M |
| Shareholders' Equity | $304.48M | $446.82M | $495.68M | $48.90M | -$11.65M | -$2.52M |
| Cash & Equivalents | $334.52M | $180.43M | $451.17M | $39.51M | $8.04M | $1.34M |
| Operating Cash Flow | -$196.01M | -$116.59M | -$42.78M | -$55.89M | -$611.1K | — |
| Capital Expenditures | $35.0K | $520.0K | $284.0K | $16.0K | — | — |
| Shares Outstanding | 64.46M | 62.87M | 49.12M | 29.36M | 360.00M | — |